NextCure, Inc.NXTCNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank81
3Y CAGR+24.1%
5Y CAGR+24.0%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+24.1%/yr
vs -37.2%/yr prior
5Y CAGR
+24.0%/yr
Consistent
Acceleration
+61.3pp
Accelerating
Percentile
P81
Within normal range
vs 5Y Ago
2.9x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 16.46% |
| Q3 2025 | 71.48% |
| Q2 2025 | -140.06% |
| Q1 2025 | 5.40% |
| Q4 2024 | -0.43% |
| Q3 2024 | 25.09% |
| Q2 2024 | 10.18% |
| Q1 2024 | -18.28% |
| Q4 2023 | -0.91% |
| Q3 2023 | 19.95% |
| Q2 2023 | -10.74% |
| Q1 2023 | 6.96% |
| Q4 2022 | 8.60% |
| Q3 2022 | -5.51% |
| Q2 2022 | 13.13% |
| Q1 2022 | -21.33% |
| Q4 2021 | 5.62% |
| Q3 2021 | 0.33% |
| Q2 2021 | -8.74% |
| Q1 2021 | -6.82% |
| Q4 2020 | 5.61% |
| Q3 2020 | -12.69% |
| Q2 2020 | -249.00% |
| Q1 2020 | 189.05% |
| Q4 2019 | -7.02% |
| Q3 2019 | 39.04% |
| Q2 2019 | -124.77% |
| Q1 2019 | -378.18% |
| Q4 2018 | -19.30% |
| Q3 2018 | 79.40% |
| Q2 2018 | -4.84% |
| Q1 2018 | 0.00% |